Anti-Interleukin-1 Agents in Adult Onset Still's Disease by Cecilia Giampietro, Bruno Fautrel

Get full text

Adult Onset Still's Disease and Autoinflammation by Petros Efthimiou, L. Nandini Moorthy, Clio P. Mavragani, Dimitris Skokos, Bruno Fautrel

Get full text

Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort by Bruno Fautrel, Annelies Boonen, Pedro M Machado, Pascal Richette, Elena Nikiphorou, Pedro D Carvalho

Get full text

Serum calprotectin levels do not predict subsequent relapse in rheumatoid arthritis in remission: a post-hoc analysis of STRASS study by Bruno Fautrel, Xavier Romand, Athan Baillet, Margot Clapasson, Minh Vu Chuong, Marie Hélène Paclet

Get full text

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects by Bruno Fautrel, Josef S Smolen, Fabrizio Benedetti, Roberto Caporali, Thomas Doerner, Burkhard Pieper, Minjun Jang

Get full text

Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort studyResearch in context by Maxime Beydon, Sandrine Pinto, Yann De Rycke, Bruno Fautrel, Xavier Mariette, Raphaèle Seror, Florence Tubach

Get full text

Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years by Bruno Fautrel, Laure Gossec, Pascal Richette, Daniel Wendling, Florian Lucasson, Krystel Aouad, Adeline Ryussen-Witrand

Get full text

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort by Cédric Lukas, Julia Mary, Michel Debandt, Claire Daïen, Jacques Morel, Alain Cantagrel, Bruno Fautrel, Bernard Combe

Get full text

Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database by Bruno Fautrel, Xavier Mariette, Yann De Rycke, Florence Tubach, Johann castaneda, Raphaele Seror, Sandrine Pinto, Alexandre Lafourcade

Get full text

Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System by Bruno Fautrel, Jean-François Bergmann, Cécile Gaujoux-Viala, Stève Bénard, Mélanie Goguillot, Asma Mélaine, Marie Guérin, Alban Edouard

Get full text

PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis by Yoram Bouhnik, Bruno Fautrel, Laurent Beaugerie, Anne-Laure Pelletier, Christine Martinez-Vinson, Ulrich Freudensprung, Amira Brigui, Janet Addison

Get full text

Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts by Bruno Fautrel, Francis Guillemin, Samuel Bitoun, Xavier Mariette, Philippe Broët, Marc Pallardy, Vincent Bouget, Julien Duquesne, Signe Hassler, Paul-Henry Cournède

Get full text

Metabolic syndrome is associated with more pain in hand osteoarthritis: Results from the DIGICOD cohort by Alix Charton, Romane Lacoste-Badie, Sophie Tuffet, Alexandra Rousseau, Emmanuel Maheu, Bruno Fautrel, Maxime Dougados, Francis Berenbaum, Alice Courties, Jérémie Sellam

Get full text

Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain by Déborah Puyraimond-Zemmour, Benjamin Granger, Anna Molto, Cécile Gaujoux-Viala, Francis Guillemin, Adeline Ruyssen-Witrand, Maxime Dougados, Bruno Fautrel, Laure Gossec

Get full text

Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study by Peter C. Taylor, Walid Fakhouri, Samuel Ogwu, Ewa Haladyj, Inmaculada de la Torre, Bruno Fautrel, Rieke Alten, Peter Nash, Eugen Feist

Get full text

Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohort. by Karine Chevreul, Georges Haour, Sandy Lucier, Stephanie Harvard, Marie-Laure Laroche, Xavier Mariette, Alain Saraux, Isabelle Durand-Zaleski, Francis Guillemin, Bruno Fautrel

Get full text

Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritis by Ruxandra Calin, Eric Caumes, Florence Reibel, Anzime Ali Mohamed, Florence Brossier, Violaine Foltz, Samia Boussouar, Bruno Fautrel, Max Maurin, Christine Katlama, Valérie Pourcher

Get full text

Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional stu... by Thomas Davergne, Rawdha Tekaya, Jérémie Sellam, Anne Tournadre, Stéphane Mitrovic, Adeline Ruyssen-Witrand, Christophe Hudry, Sabrina Dadoun, Jérôme Avouac, Bruno Fautrel, Laure Gossec

Get full text

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy by François Vercruysse, Thomas Barnetche, Estibaliz Lazaro, Emilie Shipley, François Lifermann, Alexandre Balageas, Xavier Delbrel, Bruno Fautrel, Christophe Richez, Thierry Schaeverbeke, Marie-Elise Truchetet

Get full text

Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month D... by Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Christophe Bernardeau, Yves Maugars, Mathurin Flamant, Fabienne Coury, Ben Braithwaite, Salima Hateb, Janet Addison, the PERFUSE investigators

Get full text